We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
AKYA

Price
1.26
Stock movement down
-0.04 (-3.08%)
Company name
Akoya Biosciences Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Instruments & Supplies
Market cap
62.94M
Ent value
166.73M
Price/Sales
0.72
Price/Book
4.62
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-40.85%
3 year return
-50.02%
5 year return
-
10 year return
-
Last updated: 2025-08-27

DIVIDENDS

AKYA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales0.72
Price to Book4.62
EV to Sales1.92

FINANCIALS

Per share

Loading...
Per share data
Current share count49.95M
EPS (TTM)-1.17
FCF per share (TTM)-0.98

Income statement

Loading...
Income statement data
Revenue (TTM)86.81M
Gross profit (TTM)48.23M
Operating income (TTM)-45.29M
Net income (TTM)-57.97M
EPS (TTM)-1.17
EPS (1y forward)-0.56

Margins

Loading...
Margins data
Gross margin (TTM)55.56%
Operating margin (TTM)-52.17%
Profit margin (TTM)-66.77%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash12.56M
Net receivables12.79M
Total current assets76.86M
Goodwill18.26M
Intangible assets15.27M
Property, plant and equipment0.00
Total assets129.97M
Accounts payable8.76M
Short/Current long term debt84.92M
Total current liabilities27.99M
Total liabilities116.34M
Shareholder's equity13.63M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-46.67M
Capital expenditures (TTM)2.01M
Free cash flow (TTM)-48.68M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-425.20%
Return on Assets-44.60%
Return on Invested Capital-334.88%
Cash Return on Invested Capital-281.22%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.31
Daily high1.31
Daily low1.25
Daily Volume107K
All-time high26.05
1y analyst estimate1.51
Beta1.35
EPS (TTM)-1.17
Dividend per share-
Ex-div date-
Next earnings date10 Nov 2025

Downside potential

Loading...
Downside potential data
AKYAS&P500
Current price drop from All-time high-95.16%-3.04%
Highest price drop-96.37%-56.47%
Date of highest drop14 May 20259 Mar 2009
Avg drop from high-68.10%-11.04%
Avg time to new high526 days12 days
Max time to new high1050 days1805 days
COMPANY DETAILS
AKYA (Akoya Biosciences Inc) company logo
Marketcap
62.94M
Marketcap category
Small-cap
Description
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. Akoya Biosciences, Inc. was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Employees
205
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner